Targeted treatments for cirrhosis

Author： Fallowfield Jonathan A Iredale John P

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.8, Iss.5, 2004-10, pp. : 423-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging targeted treatments for malignant glioma

By Mulholland Paul J Thirlwell Christina Brock Cathryn S Newlands Edward S

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 845-854

Informa Healthcare

Access to resources Recommend Favorite

New Treatments for Renal Cell Carcinoma: Targeted Therapies

By Saylor Philip J. Michaelson M. Dror

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 6, 2009-06 ,pp. : 645-656

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Transcutaneous Treatments of Hepatocellular Carcinoma in Patients with Cirrhosis: Present Status and Future Developments

Current Pharmaceutical Design, Vol. 13, Iss. 32, 2007-11 ,pp. : 3274-3278

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Breast Cancer: A Gateway to Revolutionary Targeted Cancer Treatments?

Current Medicinal Chemistry, Vol. 10, Iss. 7, 2003-04 ,pp. : 579-592

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights in Toxic Epidermal Necrolysis (Lyell's Syndrome): Clinical Considerations, Pathobiology and Targeted Treatments Revisited

By Paquet Philippe Piérard Gérald E.

Drug Safety, Vol. 33, Iss. 3, 2010-03 ,pp. : 189-212

Adis International

Access to resources Recommend Favorite